• AAPL 169.02
  • TSLA 162.13
  • AMZN 176.59
  • MSFT 409.06
  • INTC 34.5
  • EURUSD 1.0697
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. TA /
  3. CGEN.TA

Compugen (CGEN TA) stock market data APIs

ILA735 -20(-2.6%) as of April 24, 2024

Compugen Financial Data Overview

755
735
-
755
735
208.1-1175
638 M
89 530 K
33 459 K
0.11
2.679
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'CGEN',
Type: 'Common Stock',
Name: 'Compugen',
Exchange: 'TA',
CurrencyCode: 'ILA',
CurrencyName: 'Israeli Agora',
CurrencySymbol: 'ILA',
CountryName: 'Israel',
CountryISO: 'Il',
ISIN: 'IL0010852080',
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
}

Compugen Fundamental Data is available in our Financial Data APIs

  • Net Revenue 33 459 K
  • EBITDA -12 516 000
  • Earnings Per Share -0.79
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Compugen Earnings via APIs

  • Latest Release 2024-03-05
  • EPS/Forecast 0.23

Get Compugen End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Compugen latest news via APIs

Compugen to Receive $10 Million Milestone Payment Following Dosing of First Patient in AstraZeneca Phase 3 Rilvegostomig Trial in Biliary Tract Cancer

HOLON, Israel, Jan. 8, 2024 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today announced tha...

Compugen Regains Compliance with Nasdaq Minimum Bid Price Requirement

HOLON, Israel, Jan. 8, 2024 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, announced today th...
Do you have any questions?
support@eodhistoricaldata.com